EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Computational Evaluation of Statin Analogs Targeting HMG‐CoA Reductase for Coronary Artery Disease Treatment

Yoshua B Mtulo iD, Geradius Deogratias iD, James E Mgaya iD, Andrew S Paluch iD, Lucas Paul iD

ChemistryOpen · 2025

DOI: 10.1002/open.202500533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistryOpen, 2025. Verfasst von Yoshua B Mtulo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Dar es Salaam University College of Education, Dar es Salaam, Tanzania. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl CoA Reductases, Coronary Artery Disease. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases remain a leading cause of global mortality. While statins are pivotal in managing risk, most research focuses on their derivatives. This study provides a novel computational evaluation of statin analogs, addressing a significant literature gap. Our comprehensive in silico approach, integrating ADMET profiling, molecular docking, and extensive 200‐ns molecular dynamics (MD) simulations, investigated the pharmacokinetic behavior, binding affinities, and structural stability of five statin analogs against HMG‐CoA reductase. ADMET analysis showed that analogs of simvastatin, lovastatin, and pravastatin have favorable pharmacological profiles and low toxicity. While docking showed that simvastatin and lovastatin analogs had the strongest affinities, MD offered critical mechanistic insights. The unbound enzyme exhibited significant conformational flexibility. In contrast, binding induced a superior stabilizing effect, confining the protein to a single, compact, low‐energy state, as confirmed by free energy landscape analysis. This ligand‐induced rigidity is a powerful indicator of enhanced inhibitory efficacy and stability. Our findings highlight that statin analogs are a promising class whose unique binding dynamics offer a new, rational pathway for designing more effective HMG‐CoA reductase inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsHydroxymethylglutaryl CoA ReductasesCoronary Artery DiseaseMolecular Docking SimulationMolecular Dynamics SimulationHumansLovastatinSimvastatinPravastatin

Stichwörter der Autor:innen

ADMETHMG‐CoAcardiovascular diseasedockingmolecular dynamics simulationstatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsHydroxymethylglutaryl CoA ReductasesLovastatinSimvastatinPravastatin

Autor:innen und Institutionen

  • Department of Chemistry, Dar es Salaam University College of Education, Dar es Salaam, Tanzania.
  • Chemistry Department, College of Natural and Applied Sciences, University of Dar es Salaam, Dar es Salaam, Tanzania.
  • Department of Chemical, Paper, and Biomedical Engineering, Miami University Oxford, Ohio, USA.

ORCID-Profile: Yoshua B Mtulo, Geradius Deogratias, James E Mgaya, Andrew S Paluch, Lucas Paul

Zitieren

APA

Mtulo, Y. B., Deogratias, G., Mgaya, J. E., Paluch, A. S., & Paul, L. (2025). Computational Evaluation of Statin Analogs Targeting HMG‐CoA Reductase for Coronary Artery Disease Treatment. ChemistryOpen. https://doi.org/10.1002/open.202500533

Vancouver

Mtulo YB, Deogratias G, Mgaya JE, Paluch AS, Paul L. Computational Evaluation of Statin Analogs Targeting HMG‐CoA Reductase for Coronary Artery Disease Treatment. ChemistryOpen. 2025. doi:10.1002/open.202500533

BibTeX
@article{Mtulo2025,
  author = {Mtulo, Yoshua B and Deogratias, Geradius and Mgaya, James E and Paluch, Andrew S and Paul, Lucas},
  title = {Computational Evaluation of Statin Analogs Targeting HMG‐CoA Reductase for Coronary Artery Disease Treatment},
  journal = {ChemistryOpen},
  year = {2025},
  doi = {10.1002/open.202500533}
}
Kostenlos starten →